Related references
Note: Only part of the references are listed.Metabolomic Signature Between Metabolically Healthy Overweight/Obese and Metabolically Unhealthy Overweight/Obese: A Systematic Review
Dihe Cheng et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2021)
Plasma Free Fatty Acid Concentration as a Modifiable Risk Factor for Metabolic Disease
Gregory C. Henderson
NUTRIENTS (2021)
A Multi-Cohort Metabolomics Analysis Discloses Sphingomyelin (32:1) Levels to be Inversely Related to Incident Ischemic Stroke
Lars Lind et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2020)
Impaired glucose control is associated with multiple cardiovascular impairments
Lars Lind
CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING (2020)
A comprehensive metabolic profiling of the metabolically healthy obesity phenotype
Vibeke H. Telle-Hansen et al.
LIPIDS IN HEALTH AND DISEASE (2020)
Exploring Sphingolipid Implications in Neurodegeneration
Alice V. Alessenko et al.
FRONTIERS IN NEUROLOGY (2020)
Bile acid alterations in nonalcoholic fatty liver disease, obesity, insulin resistance and type 2 diabetes: what do the human studies tell?
Oscar Chavez-Talavera et al.
CURRENT OPINION IN LIPIDOLOGY (2019)
Are we close to defining a metabolomic signature of human obesity? A systematic review of metabolomics studies
Oscar Daniel Rangel-Huerta et al.
METABOLOMICS (2019)
The metabolites urobilin and sphingomyelin (30:1) are associated with incident heart failure in the general population
Markus Stenemo et al.
ESC HEART FAILURE (2019)
Machine learning of human plasma lipidomes for obesity estimation in a large population cohort
Mathias J. Gerl et al.
PLOS BIOLOGY (2019)
Profound Perturbation of the Metabolome in Obesity Is Associated with Health Risk
Elizabeth T. Cirulli et al.
CELL METABOLISM (2019)
Large-scale lipidomics identifies associations between plasma sphingolipids and T2DM incidence
Wee Siong Chew et al.
JCI INSIGHT (2019)
Separate and combined associations of obesity andmetabolic health with coronary heart disease: a pan-European case-cohort analysis
Camille Lassale et al.
EUROPEAN HEART JOURNAL (2018)
Branched-Chain Amino Acids as Critical Switches in Health and Disease
Zhen-Yu Zhang et al.
HYPERTENSION (2018)
Circulating Branched-Chain Amino Acids and Incident Cardiovascular Disease in a Prospective Cohort of US Women
Deirdre K. Tobias et al.
CIRCULATION-GENOMIC AND PRECISION MEDICINE (2018)
Muscle sphingolipids during rest and exercise: a C18:0 signature for insulin resistance in humans
Bryan C. Bergman et al.
DIABETOLOGIA (2016)
The Swedish CArdioPulmonary BioImage Study: objectives and design
G. Bergstrom et al.
JOURNAL OF INTERNAL MEDICINE (2015)
Hypothalamic-pituitary-adrenal axis dysregulation and cortisol activity in obesity: A systematic review
Angela C. Incollingo Rodriguez et al.
PSYCHONEUROENDOCRINOLOGY (2015)
Large-scale Metabolomic Profiling Identifies Novel Biomarkers for Incident Coronary Heart Disease
Andrea Ganna et al.
PLOS GENETICS (2014)
EpiHealth: a large population-based cohort study for investigation of gene-lifestyle interactions in the pathogenesis of common diseases
Lars Lind et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2013)
Obesity-Related Metabolomic Analysis of Human Subjects in Black Soybean Peptide Intervention Study by Ultraperformance Liquid Chromatography and Quadrupole-Time-of-Flight Mass Spectrometry
Min Jung Kim et al.
JOURNAL OF OBESITY (2013)
Plasma Sphingomyelins are Associated with Cognitive Progression in Alzheimer's Disease
Michelle M. Mielke et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
Impact of Body Mass Index and the Metabolic Syndrome on the Risk of Cardiovascular Disease and Death in Middle-Aged Men
Johan Arnlov et al.
CIRCULATION (2010)
Metabolic Profiling of Plasma in Overweight/Obese and Lean Men using Ultra Performance Liquid Chromatography and Q-TOF Mass Spectrometry (UPLC-Q-TOF MS)
Ji Young Kim et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity
K. G. M. M. Alberti et al.
CIRCULATION (2009)
Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease
James B. Meigs et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Can we identify metabolically healthy but obese individuals (MHO)?
A Karelis et al.
DIABETES & METABOLISM (2004)
Share Paper
